Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 44801-44850 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05370820
Prevention of Postpartum Hemorrhage With Tranexamic Acid
PHASE2Recruiting
120 participants
Started: Dec 28, 2022 · Completed: Oct 30, 2026
1 condition5 sponsors2 locations
NCT07036133
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
PHASE1Recruiting
24 participants
Started: Dec 28, 2022 · Completed: Sep 30, 2027
2 conditions1 sponsor2 locations
NCT05689476
Electrical Activity of the Diaphragm and Respiratory Mechanics During NAVA
NARecruiting
40 participants
Started: Dec 27, 2022 · Completed: Dec 27, 2025
5 conditions1 sponsor1 location
NCT03673748
Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells
PHASE2Recruiting
20 participants
Started: Dec 27, 2022 · Completed: Dec 31, 2027
2 conditions5 sponsors1 location
NCT05663242
The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action
PHASE4Recruiting
300 participants
Started: Dec 27, 2022 · Completed: Nov 30, 2026
3 conditions1 sponsor1 location
NCT05703789
Oral Health in Patients With Severe Eating Disorders
NARecruiting
90 participants
Started: Dec 27, 2022 · Completed: Nov 15, 2027
1 condition2 sponsors1 location
NCT05445778
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
PHASE3Recruiting
520 participants
Started: Dec 27, 2022 · Completed: Apr 30, 2029
3 conditions2 sponsors260 locations
NCT05811481
Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy
N/ARecruiting
192 participants
Started: Dec 27, 2022 · Completed: Dec 27, 2025
3 conditions1 sponsor1 location
NCT05745623
Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors
PHASE1/PHASE2Recruiting
70 participants
Started: Dec 27, 2022 · Completed: Dec 25, 2028
2 conditions1 sponsor1 location
NCT06188234
The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR Tab
N/ARecruiting
3,000 participants
Started: Dec 27, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05713435
Use of Fractional CO2 Laser Versus Erbium:YAG Laser for the Treatment of GSM in Patients Using Aromatase Inhibitors
NARecruiting
162 participants
Started: Dec 27, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05520177
A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss
PHASE3Recruiting
350 participants
Started: Dec 27, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor10 locations
NCT05423691
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
PHASE1Recruiting
24 participants
Started: Dec 27, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor4 locations
NCT05712200
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
PHASE3Recruiting
1,900 participants
Started: Dec 27, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor605 locations
NCT05667194
Phase 1 Trial of KH617
PHASE1Recruiting
45 participants
Started: Dec 26, 2022 · Completed: Aug 31, 2031
1 condition1 sponsor1 location
NCT05665244
Laryngeal Cryotherapy for Refractory Neurogenic Cough
N/ARecruiting
25 participants
Started: Dec 26, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05645107
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
PHASE3Recruiting
386 participants
Started: Dec 26, 2022 · Completed: Jun 30, 2026
5 conditions1 sponsor57 locations
NCT05917106
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
N/ARecruiting
450 participants
Started: Dec 26, 2022 · Completed: Jun 30, 2030
5 conditions1 sponsor1 location
NCT05372718
Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial
PHASE3Recruiting
170 participants
Started: Dec 26, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor5 locations
NCT05553028
Study Comparing Arthrodesis Technique of Thoracic and/or Lumbar Spine by Posterior Approach Performed by Robot-assisted Surgery (Robot Mazor X Stealth ™) Versus Conventional Surgery
NARecruiting
300 participants
Started: Dec 26, 2022 · Completed: Jan 31, 2027
4 conditions1 sponsor1 location
NCT05713123
Comparison of Record in VERITON Camera to the Anger Camera Procedure in Patients Treated by 131-iodine
NARecruiting
77 participants
Started: Dec 26, 2022 · Completed: Apr 26, 2025
1 condition1 sponsor1 location
NCT05753657
A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.
EARLY_PHASE1Recruiting
30 participants
Started: Dec 25, 2022 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT05584267
Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy
PHASE2Recruiting
140 participants
Started: Dec 25, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05665114
Natural Killer(NK) Cell Therapy in r/r AML
PHASE1Recruiting
18 participants
Started: Dec 24, 2022 · Completed: Dec 24, 2025
1 condition2 sponsors1 location
NCT05665075
Natural Killer (NK) Cell Therapy Targeting CD33 in Acute Myeloid Leukemia
PHASE1Recruiting
19 participants
Started: Dec 24, 2022 · Completed: Dec 24, 2025
1 condition2 sponsors1 location
NCT05934539
ALG.APV-527 First-in-human Study
PHASE1/PHASE2Recruiting
56 participants
Started: Dec 23, 2022 · Completed: Dec 1, 2025
1 condition2 sponsors1 location
NCT05409573
Feasibility of End-tidal Oxygen Concentration Monitoring During Preoxygenation for Intubation in the Intensive Care Unit.
NARecruiting
30 participants
Started: Dec 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04953910
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment
PHASE1Recruiting
27 participants
Started: Dec 23, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor22 locations
NCT05835609
PM534 Administered Intravenously to Patients With Advanced Solid Tumors
PHASE1Recruiting
30 participants
Started: Dec 23, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor3 locations
NCT05512351
Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma
PHASE2Recruiting
80 participants
Started: Dec 23, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05689710
The Effects of Inositol on Glucose Metabolism in Patients With Metabolic Syndrome at Risk of Cardiac Fibrosis
NARecruiting
30 participants
Started: Dec 23, 2022 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT05599178
Doppler Findings in the Fetal Cerebral Blood Vessels (VA/MCA) Within 24 Hours Before Delivery and Relation With Perinatal Outcome.
N/ARecruiting
120 participants
Started: Dec 23, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05682703
A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Nasopharyngeal Carcinoma.
N/ARecruiting
2,000 participants
Started: Dec 23, 2022 · Completed: Dec 20, 2025
2 conditions1 sponsor1 location
NCT05705869
Targeted Assessment in High-Risk paTients With dIAbetes to ideNtify Undiagnosed Heart Failure
NARecruiting
1,000 participants
Started: Dec 22, 2022 · Completed: Dec 31, 2032
5 conditions2 sponsors2 locations
NCT05920694
Restoring Metabolic and Reproductive Health With Sleep in PCOS Study, CPAP Trial
NARecruiting
20 participants
Started: Dec 22, 2022 · Completed: Apr 30, 2025
2 conditions1 sponsor1 location
NCT05377125
Neural Mechanisms of Response Inhibition Training for OCRD
NARecruiting
118 participants
Started: Dec 22, 2022 · Completed: Aug 31, 2027
3 conditions1 sponsor1 location
NCT05615597
Evaluating the Efficacy of Para-discal Infiltration in Patients With Lateralized MODIC 1 Inflammatory Disc Disease
NARecruiting
30 participants
Started: Dec 22, 2022 · Completed: Dec 22, 2025
3 conditions1 sponsor1 location
NCT05360888
Suicide Intervention for Alaska Native Youth
NARecruiting
300 participants
Started: Dec 22, 2022 · Completed: May 31, 2026
4 conditions2 sponsors2 locations
NCT05770570
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
PHASE2Recruiting
1,785 participants
Started: Dec 22, 2022 · Completed: Aug 11, 2026
5 conditions1 sponsor1 location
NCT05675930
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
PHASE2Recruiting
44 participants
Started: Dec 22, 2022 · Completed: Dec 22, 2026
3 conditions1 sponsor9 locations
NCT05704842
Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy
NARecruiting
40 participants
Started: Dec 22, 2022 · Completed: Jun 1, 2026
1 condition2 sponsors1 location
NCT05305495
Empagliflozin in Acute Heart Failure
PHASE4Recruiting
25 participants
Started: Dec 22, 2022 · Completed: Feb 28, 2027
2 conditions1 sponsor1 location
NCT05757947
Study of the No-touch Saphenous Vein Graft
NARecruiting
106 participants
Started: Dec 22, 2022 · Completed: Dec 22, 2025
5 conditions1 sponsor1 location
NCT05647122
First in Human Study of AZD9592 in Solid Tumors
PHASE1Recruiting
403 participants
Started: Dec 22, 2022 · Completed: Oct 6, 2027
4 conditions1 sponsor50 locations
NCT05691374
Evaluation of Functional and Biomechanical Outcome by Shear-wave Elastography in the Short to Intermediate Follow-up After Arthroscopic Rotator Cuff Repair
N/ARecruiting
75 participants
Started: Dec 22, 2022 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT05283330
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
PHASE1Recruiting
55 participants
Started: Dec 22, 2022 · Completed: Aug 31, 2027
6 conditions1 sponsor4 locations
NCT06239831
Postoperative Respiratory and Activity Monitoring
N/ARecruiting
30 participants
Started: Dec 22, 2022 · Completed: Jun 22, 2026
3 conditions2 sponsors1 location
NCT05557305
Changes in Motor and Cognitive Function on Unilateral Spastic Cerebral Palsy, Associated With Videogame Therapy
NARecruiting
84 participants
Started: Dec 22, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05682755
Chidamide Prevents Recurrence of High-risk AML After Allo-HSCT
PHASE1/PHASE2Recruiting
77 participants
Started: Dec 22, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06467929
Prospective Collection of Endoscopic and Histopathologic Data from Endoscopic Procedures Performed in UZ Gent
N/ARecruiting
510 participants
Started: Dec 22, 2022 · Completed: Oct 30, 2025
1 condition1 sponsor1 location